The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.
Time and money are two of the major roadblocks as the horse racing industry struggles to come to terms with medication, drug testing, and security, officials said March 4 during the joint annual meeting of Harness Tracks of America and the Thoroughbred Racing Associations.
Testing of post race samples for erythropoietin and darbepoietin antibodies will begin Nov. 1 in New York under an emergency rule approved Oct. 21 by the state's Racing and Wagering Board.
Most Popular Stories
- Large Crowd Watches American Pharoah Gallop
- More Than Just a Name for Run for Retts
- Badilla Earns Emotional Win at Golden Gate
- Team Texas Red Partners With TV Star
- Shadwell Sire Bahri Pensioned in England
- Lubash Takes West Point for Second Time
- American Pharoah Takes Easy Gallop at Spa
- Champion Divine Fortune Dies After Fall
- NBC Schedules Two-Hour Travers Broadcast
- Belmont Winner Palace Malice Retired